The Irish Pharmaceutical Healthcare Association (IPHA) has come out in support of the government's new Action Plan for Jobs, which will help create thousands of new positions through its "health innovation hub."
PMLive reports that the plan includes setting up new pharma, medical and health research centers, establishing innovative technologies to boost pharmaceutical and medical device production and provide "local high-quality, wide-scope, responsive CE mark" in order to help position the country as a global healthcare leader.
IPHA president David Gallagher said the government must still do more to ensure future industry growth.
"Our healthcare policy must support access to innovative medicines and medical technologies that are developed in Ireland. It is vital that the government continues to take a long-term view of the overall cost of healthcare," Gallagher noted.
Meanwhile, the industry got a boost recently after U.S.-based Eli Lilly and Company announced it would be expanding its pharmaceutical plant in Cork, according to the Belfast Telegraph.
The company, which already employs 700 workers at four plants in the country, said up to 300 construction jobs will need to be filled during the expansion, and an additional 200 highly skilled professionals will be hired once the site is fully operational in late 2013.